The Patent Term Restoration Act of 1981, S. 255: Hearing Before the Committee on the Judiciary, United States Senate, Ninety-seventh Congress, First Session, on S. 255, a Bill to Amend the Patent Law to Restore the Term of the Patent Grant for the Period of Time that Non-patent Regulatory Requirements Prevent the Marketing of a Patented Product. April 30, 1981U.S. Government Printing Office, 1981 - 304 lappuses |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
agency agricultural chemical American American Chemical Society analysis Association average benefits bill Chairman Charles McC chemical entities commercial Committee competition compound compulsory licensing consumers costs decline delays device drug industry drug innovation drug products economic effective patent encourage ENGMAN ethical drug extension Federal firms Genentech genetically engineered microorganisms Grabowski heptachlor incentives increased introduced investment issue John Vernon legislation major manufacturers marketplace medicines Merck million NCE's patent expiration patent laws patent lives patent protection patent restoration patent system Patent Term Restoration percent pesticide pharmaceutical industry pharmacists premarket prescription problem profits question rate of return reduced regulation regulatory process regulatory review period research and development result revenues Senator MATHIAS significant substitution laws supra note term of patent Term Restoration Act testing therapeutic therapies tion Trademark TSCA United United States Senate
Populāri fragmenti
245. lappuse - new drug" means — (1) Any drug (except a new animal drug or an animal feed bearing or containing a new animal drug) the composition of which is such that such drug is not generally recognized, among experts qualified by scientific training and experience to evaluate the safety and...
61. lappuse - Congress shall have the power .... to promote the progress of science, and the useful arts, by securing for limited times to authors and inventors, the exclusive right to their respective writings and discoveries.
198. lappuse - An Evaluation of Consumer Protection Legislation: The 1962 Drug Amendments,
113. lappuse - ... thereby fostering public welfare and education, aiding the development of our country's industries, and adding to the material prosperity and happiness of our people.
193. lappuse - Copper 340% 90% INNOVATION AND INVENTION Consumer Protection Regulation in Ethical Drugs By HENRY G. GRABOWSKI AND JOHN M. VERNON* A number of studies by economists have emphasized that government regulation often produces undesirable or unintended side effects. In this paper, we examine some effects of this nature on the structure of innovation in the pharmaceutical industry. In the first section of the paper, we review recent changes in the regulatory environment in ethical drugs and show that...
279. lappuse - ... encourage qualified men and women to stay with us and to recognize the value of their service to this country. I am sure that you are interested in knowing whether or not the various career incentives which the 84th Congress enacted into law have produced the desired effect. Certain of these measures have not been in effect for a sufficient period of time to permit a complete evaluation. We believe, however, that the legislation providing additional medical care for dependents will have a pronounced...
113. lappuse - That the objects of the incorporation shall be to encourage in the broadest and most liberal manner the advancement of chemistry in all its branches; the promotion of research in chemical science and industry; the improvement of the qualifications and usefulness of chemists through high standards of professional ethics, education, and attainments...
50. lappuse - The Federal Insecticide, Fungicide and Rodenticide Act (FIFRA) and the Toxic Substances Control Act (TSCA) authorize EPA to regulate products that adversely affect indoor air quality.
271. lappuse - ... Copyright Law have been concerned about the decreasing term of effective patent life for products that may not lawfully be sold within the United States until after they have undergone pre-marketing federal agency review. The types of products most directly affected are (i) chemical substances and pesticides which are subject to review by the Environmental Protection Agency under either the Toxic Substances Control Act or the Federal Insecticide, Fungicide, and Rodenticide Act...
198. lappuse - Given the rapid spread of health and safety regulation controls throughout all sectors of the economy, further attention to the adverse effects of regulation on industry competitive structure would seem highly desirable. They constitute a potentially important source of long-run indirect costs to society that must be weighed against the benefits of these new regulatory controls. REFERENCES Martin N. Baily, "Research and Development Costs and Returns: The US Pharmaceutical Industry,